Skip to main content
. 2020 Feb 17;117(1):320–329. doi: 10.1093/cvr/cvz345

Figure 2.

Figure 2

Study CONSORT diagram. AE, adverse event; PD, pharmacodynamic; PK, pharmacokinetic. aOnly the patients who received serelaxin were analysed and included in the PK analysis set.